Drugs and other treatments can be quite effective at killing cancer cells, yet many fall short as they struggle to penetrate ...

Mathematical models for predicting how cancer tumors in mice grow over time can give distorted results if unmeasurable data ...

The discovery could pave the way for a groundbreaking RNA-based multi-cancer treatment. Alternative RNA splicing functions ...

NYU scientists have discovered that cancer cells work together to withstand challenging conditions, revealing new ...

Circadian rhythms are endogenous time-keeping mechanisms that regulate physiological processes in response to external ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Tumours, such as some breast and ovarian cancers, can express the marker HER2. HER2 is responsible for cancer growth and is ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

The "Carcinoid Tumor Market" report has been added to ResearchAndMarkets.com's offering. The global demand for advanced carcinoid tumor treatments is witnessing a profound acceleration, as evidenced ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

Hoth Therapeutics Inc. has released preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors (GIST).